Glucocorticoidal regulation of pituitary vasopressin content in rats

Hypertens Res. 1999 Mar;22(1):39-42. doi: 10.1291/hypres.22.39.

Abstract

Although glucocorticoids are known to attenuate vasopressin (AVP) secretion, it is still controversial whether glucocorticoids act on the hypothalamo-neurohypophysial system. We report here glucocorticoidal regulation of pituitary AVP content, which is a specific indicator for the system. The hypothalamic AVP mRNA content and the pituitary AVP content were measured in rats given dexamethasone (2 mg/kg, 2 times over the course of 5 d) or the glucocorticoid receptor antagonist RU-38486 (20 mg/kg, 3 times over the course of 3 d) during euhydration or dehydration. In dexamethasone-treated rats, both the hypothalamic AVP mRNA content and pituitary AVP content decreased after dehydration. In contrast, in the RU-38486 group the hypothalamic AVP mRNA content and pituitary AVP content increased in both euhydrated and dehydrated rats. These results suggest that glucocorticoids may act on hypothalamo-neurohypophysial vasopressinergic system and attenuate its activity under both basal and dehydrated states.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Actins / metabolism
  • Animals
  • Arginine Vasopressin / genetics
  • Arginine Vasopressin / metabolism*
  • Blotting, Northern
  • Dexamethasone / pharmacology*
  • Glucocorticoids / pharmacology*
  • Hormone Antagonists / pharmacology
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Male
  • Mifepristone / pharmacology
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • RNA, Messenger / metabolism
  • Radioimmunoassay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glucocorticoid / antagonists & inhibitors

Substances

  • Actins
  • Glucocorticoids
  • Hormone Antagonists
  • RNA, Messenger
  • Receptors, Glucocorticoid
  • Arginine Vasopressin
  • Mifepristone
  • Dexamethasone